U.S. MARKETS FOR INTERVENTIONAL CARDIOLOGY PRODUCTS

323 Pages | 86 Exhibits | 2010 Analysis | Forecasts Through 2013 Product Family: Market Reports




OVERVIEW:
Every 25 seconds someone in the U.S. will suffer a coronary event, and every 60 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, nearly 18 million adults age 20 or older in the U.S. suffer from coronary heart disease (CHD), which is the single largest cause of death in the U.S. and also is the greatest cause of premature and permanent disability in the labor force; CHD is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths.

Interventional cardiologists utilize a variety of catheter-based tools for the diagnosis and treatment of heart vessel occlusions and heart defects. In 2008, approximately 6.5 million diagnostic and therapeutic interventional cardiology procedures were performed in the U.S., generating nearly $4.7 billion in corresponding product sales. It is expected that the number of interventional cardiology procedures performed in the U.S. will climb to approximately 8.1 million in the year 2013. During this same period, sales of interventional cardiology products are projected to increase at a compound annual rate of 7.5%, reaching nearly $6.7 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional cardiology devices to the U.S.

Covered topics in this report include heart disease/disorder statistics and technologies and devices for atherectomy, coronary stenting, chronic total occlusion crossing, coronary angiography, drug-eluting balloon angioplasty, guidewire-based physiologic intravascular stenosis assessment, intracardiac echocardiography, intravascular ultrasound, percutaneous transluminal coronary angioplasty, thrombectomy, transcatheter septal defect repair, and vascular access site closure.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Diagnostic Interventional Cardiology Procedures and Products
	a. Coronary Angiography
	b. Guidewire-Based Physiologic Intravascular Stenosis Assessment
	c. Intracardiac Echocardiography
	d. Intravascular Ultrasound
ii. Therapeutic Interventional Cardiology Procedures and Products
	a. Percutaneous Transluminal Coronary Angioplasty
	b. Coronary Stenting
	c. Atherectomy
	d. Chronic Total Occlusion Crossing
	e. Drug-Eluting Balloon Angioplasty
	f. Thrombectomy
	g. Transcatheter Septal Defect Repair
	h. Vascular Access Site Closure
iii. Methodology

Exhibit ES-1: Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013
Exhibit ES-2: Interventional Cardiology Products, Combined Market Forecast, 2008-2013
Exhibit ES-3: Diagnostic Interventional Cardiology, Procedure Volumes Forecast, 2008-2013
Exhibit ES-4: Diagnostic Interventional Cardiology Products, Market Forecast, 2008-2013
Exhibit ES-5: Coronary Angiography Devices, Market Forecast, 2008-2013
Exhibit ES-6: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2008-2013
Exhibit ES-7: Intracardiac Echocardiography Catheters, Market Forecast, 2008-2013
Exhibit ES-8: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
Exhibit ES-9: Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008-2013
Exhibit ES-10: Therapeutic Interventional Cardiology Products, Market Forecast, 2008-2013
Exhibit ES-11: Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2008-2013
Exhibit ES-12: Coronary Stent Systems, Market Forecast, 2008-2013
Exhibit ES-13: Atherectomy Systems, Market Forecast, 2008-2013
Exhibit ES-14: Dedicated Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
Exhibit ES-15: Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013
Exhibit ES-16: Thrombectomy Systems, Market Forecast, 2008-2013
Exhibit ES-17: Transcatheter Septal Defect Repair Devices, Market Forecast, 2008-2013
Exhibit ES-18: Vascular Access Site Closure Devices, Market Forecast, 2008-2013

1. HEART DISEASE OVERVIEW

1.1 The Heart and Circulatory System
1.2 Selected Heart Diseases/Disorders
	1.2.1 Coronary Heart Disease
		1.2.1.1 Atherosclerosis
		1.2.1.2 Angina Pectoris
		1.2.1.3 Myocardial Infarction
	1.2.2 Hypertension
		1.2.2.1 Systolic and Diastolic Pressures
		1.2.2.2 Prehypertension
	1.2.3 Cardiomyopathy
		1.2.3.1 Dilated Cardiomyopathy
		1.2.3.2 Hypertrophic Cardiomyopathy
		1.2.3.3 Restrictive Cardiomyopathy
	1.2.4 Congenital Heart Defects
		1.2.4.1 Ventricular Septal Defects
		1.2.4.2 Atrial Septal Defects
		1.2.4.3 Patent Ductus Arteriosus
	1.2.5 Heart Failure
		1.2.5.1 Disease Development
		1.2.5.2 Ejection Fraction Reduction
		1.2.5.3 Classification/Staging Systems

Exhibit 1-1: Cross-Section Diagram of the Heart
Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
Exhibit 1-3: Standard Angina Pectoris Classification
Exhibit 1-4: Angina Pectoris, Selected Statistics
Exhibit 1-5: Myocardial Infarction, Selected Statistics
Exhibit 1-6: Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State
Exhibit 1-7: Hypertension, Selected Statistics
Exhibit 1-8: Cardiomyopathy, Selected Statistics
Exhibit 1-9: Congenital Heart Defects, Selected Statistics
Exhibit 1-10: Summary, New York Heart Association Heart Failure Classification System
Exhibit 1-11: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System
Exhibit 1-12: Heart Failure, Selected Statistics

2. DIAGNOSTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

2.1 Coronary Angiography
	2.1.1 Procedures/Technologies
	2.1.2 Products
	2.1.3 Market Forecast
	2.1.4 Competitors
2.2 Guidewire-Based Physiologic Intravascular Stenosis Assessment
	2.2.1 Procedures/Technologies
	2.2.2 Products
	2.2.3 Market Forecast
	2.2.4 Competitors
2.3 Intracardiac Echocardiography
	2.3.1 Procedures/Technologies
	2.3.2 Products
	2.3.3 Market Forecast
	2.3.4 Competitors
2.4 Intravascular Ultrasound
	2.4.1 Procedures/Technologies
	2.4.2 Products
	2.4.3 Market Forecast
	2.4.4 Competitors

Exhibit 2-1: Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013
Exhibit 2-2: Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2008-2013
Exhibit 2-3: Coronary Angiography, Procedure Volumes Forecast, 2008-2013
Exhibit 2-4: 2010, Selected Angiography Catheters
Exhibit 2-5: 2010, Selected Diagnostic Guidewires
Exhibit 2-6: 2010, Selected Introducers/Sheaths
Exhibit 2-7: Coronary Angiography Devices, Market Forecast, 2008-2013
Exhibit 2-8: 2009, Coronary Angiography Devices Market, Share by Supplier
Exhibit 2-9: Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, 2008-2013
Exhibit 2-10: 2010, Selected Guidewires for Physiologic Intravascular Stenosis Assessment
Exhibit 2-11: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2008-2013
Exhibit 2-12: 2009, Physiologic Intravascular Stenosis Assessment Guidewires Market, Share by Supplier
Exhibit 2-13: Intracardiac Echocardiography, Procedure Volumes Forecast, 2008-2013
Exhibit 2-14: 2010, Selected Intracardiac Echocardiography Catheters
Exhibit 2-15: Intracardiac Echocardiography Catheters, Market Forecast, 2008-2013
Exhibit 2-16: 2009, Intracardiac Echocardiography Catheters Market, Share by Supplier
Exhibit 2-17: Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013
Exhibit 2-18: 2010, Selected Intravascular Ultrasound Catheters
Exhibit 2-19: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
Exhibit 2-20: 2009, Intravascular Ultrasound Catheters Market, Share by Supplier

3. THERAPEUTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

3.1 Percutaneous Transluminal Coronary Angioplasty
	3.1.1 Procedures/Technologies
		3.1.1.1 Approaches
		3.1.1.2 Complications/Efficacy
		3.1.1.3 Procedure Volumes Forecast
	3.1.2 Products
		3.1.2.1 Balloon Catheters
		3.1.2.2 Guiding Catheters
		3.1.2.3 Guidewires
		3.1.2.4 Introducers/Sheaths
		3.1.2.5 Accessories
	3.1.3 Market Forecast
	3.1.4 Competitors
3.2 Coronary Stenting
	3.2.1 Procedures/Technologies
		3.2.1.1 Stent Materials, Coatings/Surfaces, and Anti-Restenosis Agents
		3.2.1.2 Stent Deployment
		3.2.1.3 Indications
		3.2.1.4 Complications/Efficacy
		3.2.1.5 Procedure Volumes Forecast
	3.2.2 Products
	3.2.3 Market Forecast
	3.2.4 Competitors
3.3 Atherectomy
	3.3.1 Procedures/Technologies
	3.3.2 Products
	3.3.3 Market Forecast
	3.3.4 Competitors
3.4 Chronic Total Occlusion Crossing
	3.4.1 Procedures/Technologies
	3.4.2 Products
	3.4.3 Market Forecast
	3.4.4 Competitors
3.5 Drug-Eluting Balloon Angioplasty
	3.5.1 Procedures/Technologies
	3.5.2 Products
	3.5.3 Market Forecast
3.6 Thrombectomy
	3.6.1 Procedures/Technologies
	3.6.2 Products
	3.6.3 Market Forecast
	3.6.4 Competitors
3.7 Transcatheter Septal Defect Repair
	3.7.1 Procedures/Technologies
		3.7.1.1 Atrial Septal Defect Repair
		3.7.1.2 Patent Ductus Arteriosus Repair
		3.7.1.3 Ventricular Septal Defect Repair
		3.7.1.4 Procedure Volumes Forecast
	3.7.2 Products
	3.7.3 Market Forecast
	3.7.4 Competitors
3.8 Vascular Access Site Closure Devices
	3.8.1 Procedures/Technologies
	3.8.2 Products
	3.8.3 Market Forecast
	3.8.4 Competitors

Exhibit 3-1: Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013
Exhibit 3-2: Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2008-2013
Exhibit 3-3: Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting, Procedure Volumes Forecast, 2008-2013
Exhibit 3-4: 2010, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters
Exhibit 3-5: 2010, Selected Guiding Catheters for Coronary Interventions
Exhibit 3-6: 2010, Selected Guidewires for Coronary Interventions
Exhibit 3-7: 2010, Selected Introducers/Sheaths for Coronary Interventions
Exhibit 3-8: 2010, Selected Inflation Devices for Coronary Interventions
Exhibit 3-9: Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2008-2013
Exhibit 3-10: 2009, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier
Exhibit 3-11: 2010, Selected Anti-Restenosis Agents
Exhibit 3-12: Coronary Stenting, Procedure Volumes Forecast, 2008-2013
Exhibit 3-13: 2010, Selected Coronary Stents
Exhibit 3-14: Coronary Stent Systems, Market Forecast, 2008-2013
Exhibit 3-15: 2009, Coronary Stent Systems Market, Share by Supplier
Exhibit 3-16: Atherectomy, Procedure Volumes Forecast, 2008-2013
Exhibit 3-17: 2010, Selected Atherectomy Systems
Exhibit 3-18: Atherectomy Systems, Market Forecast, 2008-2013
Exhibit 3-19: 2009, Atherectomy Systems Market, Share by Supplier
Exhibit 3-20: Chronic Total Occlusion Crossing,Procedure Volumes Forecast, 2008-2013
Exhibit 3-21: 2010, Selected Chronic Total Occlusion Crossing Devices
Exhibit 3-22: Dedicated Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
Exhibit 3-23: Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013
Exhibit 3-24: Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013
Exhibit 3-25: Thrombectomy, Procedure Volumes Forecast, 2008-2013
Exhibit 3-26: 2010, Selected Thrombectomy Systems
Exhibit 3-27: Thrombectomy Systems, Market Forecast, 2008-2013
Exhibit 3-28: 2009, Thrombectomy Systems Market, Share by Supplier
Exhibit 3-29: Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2008-2013
Exhibit 3-30: 2010, Selected Transcatheter Septal Defect Repair Devices
Exhibit 3-31: Transcatheter Septal Defect Repair Devices, Market Forecast, 2008-2013
Exhibit 3-32: 2009, Transcatheter Septal Defect Repair Devices Market, Share by Supplier
Exhibit 3-33: Vascular Access Site Closure, Procedure Volumes Forecast, 2008-2013
Exhibit 3-34: 2010, Selected Vascular Access Site Closure Devices
Exhibit 3-35: Vascular Access Site Closure Devices, Market Forecast, 2008-2013
Exhibit 3-36: 2009, Vascular Access Site Closure Devices Market, Share by Supplier

4. COMPANY PROFILES

4.1 Abbott Laboratories
4.2 AGA Medical/AGA Medical Holdings, Inc.
4.3 Arrow International/Teleflex, Inc.
4.4 Boston Scientific Corporation
4.5 B. Braun Melsungen AG
4.6 Cordis Corporation/Johnson & Johnson
4.7 FlowCardia, Inc.
4.8 InSitu Technologies, Inc.
4.9 MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
4.10 Medtronic, Inc.
4.11 Merit Medical Systems, Inc.
4.12 NMT Medical, Inc.
4.13 OrbusNeich
4.14 Spectranetics Corporation
4.15 St. Jude Medical
4.16 Terumo Medical Corporation/Terumo Corporation
4.17 Vascular Solutions, Inc.
4.18 Volcano Corporation

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. AGA Medical/AGA Medical Holdings, Inc.
  3. Arrow International/Teleflex, Inc.
  4. Boston Scientific Corporation
  5. B. Braun Melsungen AG
  6. Cordis Corporation/Johnson & Johnson
  7. FlowCardia, Inc.
  8. InSitu Technologies, Inc.
  9. MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
  10. Medtronic, Inc.
  11. Merit Medical Systems, Inc.
  12. NMT Medical, Inc.
  13. OrbusNeich
  14. Spectranetics Corporation
  15. St. Jude Medical
  16. Terumo Medical Corporation/Terumo Corporation
  17. Vascular Solutions, Inc.
  18. Volcano Corporation
Contact Us

Need help finding medtech research? Let us help you!